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[‘H]PN 200-110, a potent chiral benzoxadiazol 1,Cdihydropyridine Ca’+antagonist was used to label 
guinea pig skeletal muscle Ca 2+ channels. [3H]PN 200-110 binds with a & of -1 nM to a homogeneous 
population of non-interacting binding sites; d-cis-diltiazem, but not 1-cis-diltiazem increases the Bmax of 
(3H]PN 200-110 by 25% and slows the dissociation rate 3-fold at 37°C. Target size analysis of the 
[3H]PN 200-llO-labelled Ca2+ channels with 10 MeV electrons gave an M, of 136000 which was reduced 
to 75000 by d-cis-diltiazem treatment of membranes. It is concluded that positive heterotropic allosteric 
regulation by d-cis-diltiazem is accompanied by channel oligomer dissociation. 
~QI]PN 200-110 d-cis-Diltiazem Skeletal muscle Target size Cti’ channel M, 
1. INTRODUCTION 
The Ca2+ channels of skeletal muscle have been 
directly identified with the Ca2+ antagonist 
[3H]nimodipine. [‘H]Nimodipine binds to a homo- 
geneous population of saturable, stereospecific, 
non-interacting binding sites in a fully reversible 
manner [l]. Using [‘Hlnimodipine to label Ca2+ 
channels, subcellular fractionation of skeletal mus- 
cle has led to the conclusion that the [3H]nimo- 
dipine-labelled Ca2+ channel is located almost ex- 
clusively in t-tubules [2]. This result is in agreement 
with findings from electrophysiologicalstudies [3]. 
pine [5]. Here, we report on the positive hetero- 
tropic allosteric regulation of t3H]PN 200-l 10 
binding by d-cis-diltiazem and the associated 
parallel reduction of the Ca2+ channel molecular 
size as assessed by in situ target size analysis. 
2. MATERIALS AND METHODS 
We have labelled skeletal muscle Ca2+ channels 
with the potent Ca” antagonist [‘H]PN 200-110 
(isopropyl 4-(2,1,3-benzoxadiazol-4-y&1 ,Cdihy- 
dro-2,6-dimethyl-5-methoxycarbonyl-pyridine-3- 
carboxylate) [4] which labels more channels than 
[‘Hlnimodipine, [3H]nitrendipine or [3H]nifedi- 
2.1. Radiation-inactivation of C& channels 
Male or female guinea pigs were stunned and 
bled and skeletal muscle membranes prepared as in 
[l]. The membranes were then pre-incubated at 
37°C for 30 min under 3 conditions: 
(i) In 50 mM Tris-HCl supplemented with 
0.1 mM phenylmethylsulfonyl fluoride 
(PMSF), pH 7.4 (buffer A); 
(ii) In buffer A supplemented with 10pM d-cis- 
diltiazem; 
(iii) With 10 /IM 1-cis-diltiazem. 
* To whom all correspondence should be addressed 
+ This work is part of the theses of A.G. and D.R.F. 
The membranes were then flash-frozen in liquid 
nitrogen in 2-ml aliquots. Pretreated membranes 
were irradiated with 10 MeV electrons from a 
linear accelerator (CSF, Thompson, Paris) using a 
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focused electron beam. The temperature was 
automatically maintained at - I lO*C as in [6]. 
Dosimetry was performed with radiochromic dye 
films [i’]. The dose of radiation reducing the star- 
ting biological activity to 37% (I&) was used to 
compute the &&-value from the empirical formula 
[8]: 
M; =f 
6.4 x lo5 
D37 Mad1 
where: 
- 110°C [7]. 
f = a temperature correction factor of 2.8 at 
2.2. Ligand-binding assays 
L~gand-binding assays were performed under 
sodium vapour lighting in 1 .O ml in buffer A, with 
20- 100 fig membrane protein/ml and unlabeiled 
drugs as indicated. Non-saturable t3H]PN 200-l 10 
(2.6 Cilmmol, 2 95(rlo radiochemic~ purity)- 
binding was defined either by 1 or 10 FM unlabell- 
ed PN 200-l 10 or by 1 pM unlabelled nimodipine, 
all of which gave identical results. Non-saturable 
binding was 3-8% of bound t3H]PN 200-110 at 
the & of [3H]PN 200-110. After 15 min incuba- 
tion, bound and free t3H]ligand were separated by 
rapid filtration as in [l]. 
Acetylcholine sterase (EC 3.1.1.7) was assayed 
as in [9] with a Beckman DU 8 spectrophotometer. 
2.3. Experimental design and statktics 
Data are presented from 3 complete and in- 
dependent radiation-inactivation experiments in 
which the differentially preincubated membranes 
were irradiated simultaneously. The acetylcholine 
esterase activity determination and binding assays 
were performed in the same samples. All means are 
arithmetic means, all p-values were computed with 
the two-tailed Student’s t-test. 
2,4. Materials 
Radiochromic dye films were purchased from 
Far-West Technology (Goleta CA). Sources for 
other chemicals are given in [ 1,5]. 
3. RESULTS 
t3H]PN 200-110 binds to a saturable, non- 
interacting set of binding sites in skeletal muscle 
membranes. The Kd of [‘HJPN 200-l 10 at 37°C is 
1.4 + 0.5 nM (n = 3) and the Bmax is 21 + 
1.5 pmol/mg protein. Fig,la shows a saturation 
experiment performed over a 2200-fold range of 
free [3H]ligand concentrations. As can be seen, 
0 10 20 30 0.2 0.4 0.6 -1 0 t 2 
FREE [nM] BOUND/ FREE log FREE [nM] 
Fig.2. (A) Stereoselective inhibition of [‘H]PN 2~110-binding tb skeletal muscle membranes by the optical 
enantiomers of PN 200-110. B is the concentration of the specifically bound t3H]ligand in the absence and Bo in the 
PN 200-I 10 is subtracted from total binding to yield saturable (A,) binding. The range of the free ~+~n~tiomer of 
J3H]PN 200-110 employed, is from 0.016-34 nM. As can be seen at the iyd, the binding to saturable binding sites is 
>90% of filter-retained radioactivity. The assay is performed in 1.0 ml at 37°C at 32 pg protein/ml. (B) Linear 
transformation of the data (shown in A) presented as a Hofstee plot. Linear regression analysis gives a Bmax of 0.61 nM, 
which is equivalent to 19.3 pmob’mg protein. (C) The concentration of bound ligand is plotted as a function of the log 
free-liiand. Non-linear curve fitting to the general dose-response equation yields a & (t asymptotic standard 
deviation) of 1.1 -+ 0.1 nM and a Bmrut of lg.1 f 0.2 pmol/mg protein. 
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blank values are extremely low and the signal to 
noise ratio is remarkably good for this labelled 
Ca2+ antagonist in skeletal muscle membranes. 
The transformations of the equilibrium-binding 
data show linearity in the Hofstee plot and the 
symmetry of the bound vs log free-ligand plot. 
3.2. Characteristics of ?HJPN 200-IIO-binding 
The Ca2+ channel-binding of [3H]PN 200-l 10 is 
stereoselectively inhibited by the optically pure 
enantiomers of PN 200-l 10, ( + )205-033 and 
(-)205-034 (fig.2). The binding-inhibition data of 
both enantiomers are characterized by a slope fac- 
tor of 1.0 f 0.1, with the (+)enantiomer being 
about 300-times more potent than the 
( - )enantiomer. This stereoselective inhibition is 
similar to that reported for the binding of these 
enantiomers at the [3H]nimodipine-labelled 
skeletal muscle Ca2+ channel [l]. As the 
(+)enantiomer is about 300-times more potent 
than the (-)enantiomer we have used the concen- 
tration of the free ( + )enantiomer of 
[3H]PN 200-110 in all calculations neglecting the 
( - )enantiomer . 
3.3. Regulation of fHJPN 200-IIO-binding by 
diltiazem diastereoisomers 
d-cis-Diltiazem, but not I-cis-diltiazem, increases 
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Fig.2. (A) Stereoselective inhibition of t3H]PN 200-llO-binding to skeletal muscle membranes by the optical 
enantiomers of PN 200-110. B is the concentration of the specifically bound [3H]ligand in the absence and BO in the 
presence of the competitor, respectively. Receptor is 1.5 nM. bound ligand (B,), 1.2 nM and the [‘Hlligand, 6.7 nM. 
The (+)enantiomer of PN 200-110, (+)205-033 (m) is about 300-times more potent than the (-)enantiomer of 
PN 200-110, (-)205-034 (0). The &values are calculated by eq. (22) and eq. (23) of [12]: (+)205-033, 1.3 nM; 
(-)205-034, 375 nM. (B) Stereospecific interaction of d-cis-diltiazem (+) and I-cis-diltiazem (0) with 
[‘H]PN 200-l lo-labelled Ca2+ channels. d-&Diltiazem causes a small (-25%) stimulation of Ca” channel-labelling 
by [3H]PN 200-110; I-cis-diltiazem causes only a small inhibition (15% at 50pM). Protein is 19.2 @g/ml and bindable 
[3H]PN 200-110, 5.0 nM. (C) Dissociation of ([‘H]PN 200-110 Ca” -channel) complexes induced by blockade of the 
association reaction with 1 /tM unlabelled PN 200-l 10. Bt is the saturable binding at the times indicated, and Be satur- 
able binding at equilibrium (time = zero). B, is 0.55 nM in the absence of d-cis-diltiazem and 0.70 nM in the presence 
of 10 PM d-cis-diltiazem; the concentration of bindable [3H]PN 200-l 10 is 4.2 nM and protein, 43.9 pg/ml. In this 
experiment, the k-i in the absence of d-cis-diltiazem (A) was 0.25 min-’ and in the presence of d-cis-diltiazem (A) 
0.07 min-‘. 
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in a concentration-dependent manner [3H]PN 
200-l lo-labelling of Ca2+ channels. The EDso of 
d-cis-diltiazem stimulation is l-2 ,uM (fig.2) which 
is in the same range as the EDso of d-cis-diltiazem 
to stimulate [3H]nimodipine-binding [l]. The 
stimulation of [3H]PN 200-llO-labelling of cal- 
cium channels by d-cis-diltiazem is due to an in- 
Fig.3. Radiation inactivation of [3H]PN 200-l lo- 
labelled Ca2’ channels. (A) A is the specific binding at 
a given dose of radiation, and A0 the saturable binding 
in non-irradiated controls. The skeletal muscle mem- 
branes are either pre-incubated and assayed in buffer 
(H), 10 pM d-cis-diltiazem (0) or lO,uM I-cis-diltiazem 
(A). In this experiment, [3H]PN 200-110 is 5.3 nM and 
protein, 6Opg/ml. In the non-irradiated controls the 
concentrations of specifically bound [3H]PN 200-l 10 
are as follows: for buffer pre-incubation, 1.59 + 
0.04 nM; for 10 pM d-cis-diltiazem pre-incubation, 2.02 
f 0.05 nM; for I-cis-diltiazem pre-incubation, 1.23 + 
0.06 nM (n = 3). The Dsr-values of the [3H]PN 200-l lo- 
labelled Ca2+ channels under the pre-incubation condi- 
tions are, buffer 037 = 14.01 Mrad (Mr 128000), 1OpM 
d-cis-diltiazem, Ds7 = 23.3 Mrad (Mr 77000), 1OpM 
I-cis-diltiazem 037 = 12.9 Mrad (Mr 139000). (B) The Kd 
of [3H]PN 200-110 for residual Ca2+ channels is not 
changed by the radiation for doses up to 27 Mrad. 
crease in B,, from 21 f 1.5 pmol/mg protein 
(n = 3) to 26 + 1 pmol/mg protein (n = 3; p < 
0.05). 
Table 1 
MI-values of Ca2’ channels and an enzyme standard as determined by radiation inactivation 
Pre-incubation condition 
Buffer 10 uM d-cis-diltiazem 10 uM I-cis-diltiazem 
Skeletal muscle Ca2+ channels labelled with 
[3H]PN 200-l 10 
(c) (a,b) 
Skeletal muscle Ca2+ channels labelled with 
[3H]nimodipinea 
Skeletal muscle acetylcholine esterase 
Skeletal muscle Ca2+ channels labelled with 
[3H]nitrendipineb 
* Data are from Ferry et al., submitted 
136000 k 12000 
178000 + 7000 
66000 
210000 f 20000 
(d) 
75000 f 4800 
111000 f 7000 
58ooO 
n.d. 
123000 f 6700 
158000 + 7100 
69000 
n.d. 
b Data are from [ll]. Data for the M, of the membrane-bound acetylcholine esterase, which is the internal control, are 
included 
n.d., not determined 
M,-values are calculated from monophasic decay curves of the given biological activity according to the empirical 
formula in [8]. Means with standard error fqr n = 3 experiments are shown: (a) p < 0.01 for [3H]PN 200-l lo-labelled 
calcium channels pre-incubated in 10pM ‘d-cis-diltiazem vs pre-incubation in buffer; (b) p < 0.013 for 
[‘H]PN 200-l lo-labelled calcium channels vs [3H]nimodipine-labelled calcium channels, both pre-incubated with 10 pM 
d-cis-diltiazem; (c)p < 0.04 for [3H]PN 200-l lo-labelled vs [3H]nimodipine-labelled, both pre-incubated in buffer; (d) 
p < 0.06 for both pre-incubated in I-cis-diltiazem 
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3.4. Reversibility and dissociation kinetics 
The binding of [3H]PN 200-110 to Ca2+ chan- 
nels is fully reversible. When an equilibrium 
population of (channel-[3H]PN 200-100) com- 
plexes is perturbed by addition of 1 PM unlabelled 
PN 200-l 10, the complexes decay monoexponen- 
tially with respect to time. At 37°C the k-1 is 
0.3 min-‘. In the presence of a saturating con- 
centration of d-cis-diltiazem the k-i of (channel- 
t3H]PN 200-l 10) complexes is 0.07 min-’ which is 
4-times smaller than in the absence of d-cis- 
diltiazem (fig.2). 
3.5. Target size analysis 
Irradiation of skeletal muscle microsomes 
decreases [3H]PN 200-l lo-labelling of Ca2+ chan- 
nels, due to a decrease in B,,. The Kd of 
[3H]PN 200-110 for the remaining Ca2’ channels 
remains unchanged (fig.3a). When the decline of 
[3H]PN 200-l 10 Ca2+ channel-labelling is plotted 
against the radiation dose, a monoexponential 
decay curve is found for membranes which were 
pre-incubated in buffer A or in buffer A sup- 
plemented with 10 pM d- or 1-cis-diltiazem, respec- 
tively (fig.3b). These monoexponential decay 
curves are shown as linear transformations in 
fig.3c. 
When membranes are pre-incubated in buffer A, 
the Ds7 of the [3H]PN 200-l lo-labelled Ca” chan- 
nel is 13.2 + 0.2 Mrad (n = 3), which corresponds 
to Mr 136000. Pre-incubation with d-cis-diltiazem 
increased the 037 to 24.3 f 2 Mrad (n = 3), cor- 
responding to a decrease in M, of 61000 mass 
units. Pre-incubation with 1-cis-diltiazem does not 
significantly decrease the MI (table 1). The Mr of 
the membrane-bound acetylcholine sterase, which 
is measured as an internal standard, is identical for 
all 3 pre-incubation conditions (table 1). 
4. DISCUSSION 
Here we found that the apparent molecular size 
of the [3H]PN 200-110~labelled Ca2+ channel is 
136000. Pre-incubation with d-cis-diltiazem, but 
not 1-cis-diltiazem, reduced the M, of the 
[3H]PN 200-l lo-labelled channel. The specificity 
of the d-cis-diltiazem regulation of the Ca2+ chan- 
nel M, is underlined by the ineffectiveness of l-cis- 
diltiazem to induce a decrement of the M,, and the 
fact that acetylcholine esterase has an identical M, 
under all 3 pre-incubation conditions. This rules 
out the possibility that non-specific effects such as 
‘radical capture’ are responsible for the observed 
M, regulation. In this respect, the Ca2+ channel is 
analogous to the benzodiazepine receptor/chloride 
ionophore, where y-aminobutyric acid acts a 
positive heterotropic allosteric regulator and 
thereby induces a decrease in molecular size of the 
[3H]flunitrazepam-labelled complex [lo]. 
Our value for the M, of the skeletal muscle Ca2+ 
channel labelled with PN 200-l 10 is smaller than 
that in [ 111. We can rule out methodological or 
species differences to explain this apparent 
discrepancy, because we have measured the Mr of 
the Ca2+ channel with different labelled 
1 ,Cdihydropyridine Ca2+ antagonists and our data 
(e.g., with [3H]nimodipine) are statistically in- 
distinguishable from the M,-value reported in [l l] 
(see table 1). It should be noted that in skeletal 
muscle the 3-nitrophenyl 1 ,Cdihydropyridines, 
[3H]nitrendipine and t3H]nimodipine label an 
identical number of high-affinity binding sites, 
whereas the benzoxadiazol 1 ,Cdihydropyridine 
derivative [3H]PN 200-l 10 labels significantly 
more sites [5]. In addition, the d-cis-diltiazem 
stimulation of [3H]PN 200-l 10 binding capacity is 
only 20% compared to the 200-300% increase 
seen with [3H]nitrendipine or [3H]nimodipine. We 
have suggested that this may be due to an ‘efficacy 
factor’ whereby the given 1,4_dihydropyridine 
stabilizes a conformer of the channel with high af- 
finity for this class of drugs [5]. Because 
[3H]PN 200-110 (in comparison to nifedipine, 
nitrendipine and nimodipine) can stabilize more 
Ca2+ channels in a high affinity state, the action of 
d-cis-diltiazem (which allows channels at 37°C to 
have high affinity for 1,4_dihydropyridines) is 
much less pronounced. 
As can be seen from table 1, 
[3H]PN 200-l IO-labelling of Ca2+ channels can be 
also differentiated from [3H]nimodipine (or 
[3H]nitrendipine)-labelling by in situ target size 
analysis. Thus [3H]PN 200-llO-labelling of Ca2+ 
channels yields M,-values which are 37000-42000 
mass units smaller than the corresponding M,- 
values of [3H]nimodipine-labelled channels. 
How can we explain the difference in M, 
measured with [3H]PN 200-110 as opposed to 
nimodipine or nitrendipine and the decrement in 
functional size induced by d-cis-diltiazem? In the 
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Table 2 
Average target sizes of putative lements of the skeletal muscle Ca2+ channel in situ 
June 1983 
Element M, Pre-incubation 
condition 
Ca2+ channel label Proposed function 
<75ooo 
75ooo 
lllooo 
6Oooo 
138000 
178000 
derived Binds 1 ,Cdihydropyridines 
d-cis-Diltiazem [3H]PN 200-l 10 Facilitates PN 200-l o-binding 
d-cis-Diltiazem [3H]Nimodipine Facilitates nimodipine-binding 
derived Dissociated by d-cis-diltiazem 
buffer [3H]PN 200-l 10 
buffer [3H]Nimodipine 
Elements of the model are the limiting largest structures which allow the data of the target size analysis (table 1) to 
be unambiguously interpreted. In frozen membranes cyalways behaves as an independent target, @?-6) and (7.6) are 
assembled targets which are dissociated upon pre-treatment with d-cis-diltiazem. The MT of 6 is derived by subtracting 
the Mr of either [3H]nimodipine or [3H]PN 200-l IO-labelled Ca2+ channels pre-incubated with d-cis-diltiazem from the 
M, of buffer pre-incubated channels. The M, of (Y, as a condition of the model, must be smaller than any measured Mr 
absence of more biochemical information on the 
structural composition of the Ca2+ channel we 
would like to propose the following model. This 
model uses the assumption that a single hit 
destroys the total structure of a given ‘target’ [8] 
whether that target is composed of a single pro- 
tomer or assembled from heterologous or 
homologous protomers. Assume that the Ca2+ 
channel consists of 4 elements (a, p, y, 6) which 
may or may not correspond to the true protomers 
of the oligomeric channel. These elements are 
defined as the largest components required for the 
measured biological activity; e.g., [3H]PN 
200-l 10, [jH]nimodipine or [3H]nitrendipine- 
labelling after irradiation. Table 2 lists the 
elements of the model and their measured or 
deduced &values under the different experimen- 
tal conditions. The element cx (carrying the 
1 ,Cdihydropyridine Ca2+ antagonist binding site) 
has to associate with the (facilitatory) element ,& 
when PN 200-110 labels the channel, but with the 
(facilitatory) element y when [3H]nimodipine or 
[3H]nitrendipine labels. 
The MI difference (7-p) is 40000, because 
under all preincubation conditions (table 1) the 
channel assayed by [3H]nimodipine or [3H]nitren- 
dipine is larger by this increment than when 
assayed with PN 200-l 10. The conclusion is, that 
we have not determined the Mr of cy, but that of the 
facilitatory elements Q3 or y). The following rank 
order of M,-values must then apply: (Y < P < y. 
68 
Because preincubation with d-cis-diltiazem 
decreases the M, by about 60000 we have to 
postulate that p and y are functionally coupled to 
the element 6; S is the element which d-cis- 
diltiazem uncouples from either ,& or y. Therefore, 
according to the model, in buffer-preincubated 
membranes, frozen at - 1 lO”C, the elements exist 
as cy, Q3.S) and (r-8) where @3.S) and y-6) are 
assembled (coupled) elements. In d-cis-diltiazem- 
preincubated membranes the elements exist as LY, 
P, Y9 6. 
Admittedly this model is speculative but it can 
explain the experimental results and gives an 
estimate of the functional size of the 
1,Cdihydropyridine binding site. In any event our 
data demonstrate that 1,6dihydropyridines in- 
teract differently with the Ca2+ channels as shown 
by target size analysis in this study and by com- 
parative ligand-binding experiments elsewhere [5]. 
Our experiments have yielded the important result 
that the allosteric regulator d-cis-diltiazem 
decreases the in situ Mr of the Ca2+ channel as 
labelled by 1,6dihydropyridines, and that slow 
channel blocker-channel interactions are of a 
complex nature at the molecular level. 
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